Skip to main content
SH

Singlepoint Healthcare

Singlepoint Healthcare provides coordinated specialty care for patients managing chronic inflammatory and autoimmune diseases. The organization integrates expert specialists in neurology, rheumatology, and immunology with necessary support services under one system. This model aims to deliver connected, patient-centered management for complex conditions to improve patient quality of life.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients with complex inflammatory diseases, particularly in neurology, rheumatology, and immunology, often face fragmented care pathways. This fragmentation leads to difficulties in accessing coordinated specialist expertise and essential services, hindering effective diagnosis and management of autoimmune conditions.

Solution

Singlepoint Healthcare provides an integrated care model that consolidates access to multidisciplinary specialists, diagnostics, and support services for patients with inflammatory diseases. Our platform ensures seamless coordination, acting as a single point of contact to streamline the patient journey. We focus on delivering comprehensive, patient-centered management for complex autoimmune conditions, aiming to improve patient outcomes and quality of life.

Target Audience

The primary target audience includes individuals diagnosed with chronic inflammatory and autoimmune diseases requiring specialized, coordinated care, as well as healthcare providers seeking to improve patient management pathways.

Features

  • Integrated access to specialists in neurology, rheumatology, and immunology.
  • Coordinated diagnostics and infusion/injection services.
  • Dedicated patient navigators serving as a single point of contact.
  • Streamlined appointment scheduling and timely treatment initiation.
  • Financial counseling and assistance program exploration.
  • Cross-service care coordination to prevent delays and confusion.
  • Access to cutting-edge therapies and advanced treatment options.
  • Clinical research participation opportunities.
This profile is AI-generated and may contain inaccuracies.